Skip to main content



Local Cdiff information for Michigan

Michigan

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.



Local Cdiff information for Michigan

Michigan

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.

Providers


Dr. Teena Chopra, MD, MPH

Professor, Infectious Diseases, Wayne State University; Corporate Medical Director of Infection Prevention and Hospital Epidemiology and Antibiotic Stewardship, DMC and WSU
Detroit Medical Center, Wayne State University
4201 St Antoine
Detroit48201
313-745-4210
FMT Provider: Yes

Dr. Mayur Ramesh, MD

Henry Ford Health System
2799 W Grand Blvd, K13
Detroit48202
(800) 436-7936
FMT Provider: Yes

Dr. John Yung-Chong Kao, MD

Professor, Internal Medicine
Gastroenterology Clinic Taubman Center
1500 E Medical Center Dr
Floor 3, Reception D
Ann Arbor48109
(888) 229-7408
FMT Provider: Yes

Regulation


C. diff Infections

Total Reported Cases: 9470
Hospital Onset: 4546
Community Onset: 4924
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.75

State Reporting Laws

Data Submission Required: No
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available

State Contact

Brenda Brennan, MSPH
HAI Coordinator / SHARP Unit Manager, Surveillance for Healthcare-Associated and Resistant Pathogens (SHARP) Unit
Michigan Department of Health and Human Services
Capitol View Building, 5th floor
201 Townsend, 5th Floor
Lansing, 48913
(517) 284-4945
(517) 335-8263

CLINICAL TRIALS


DSM 33864

Official Title: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Tolerability and Effect of Bacillus Velezensis DSM 33864 on the Reduction of Risk of Recurrent Clostridioides Difficile Infection (rCDI) in Adults With a History of rCDI
Trial No. NCT05606159
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Novozymes A/S
Contact: Victoria Oyedokun, PhD
+491723244702
Gender: All
Age: 18 Years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older

CRS3123

Official Title: A Phase 2, Randomized, Double-Blind, Comparator-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CRS3123 Compared With Oral Vancomycin in Adults With Clostridioides Difficile Infection
Trial No. NCT04781387
Type: Interventional
Recruitment: Recruiting
Sponsor: Crestone, Inc.
Contact: Wendy Ribble
303-668-2516
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older